Delivery Order SPE2DB24D1205-SPE2DB25FDAMY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Lisinopril 10 mg, valued at $1,563.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively bid. The contract is scheduled for ultimate completion on September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lisinopril is an ACE inhibitor...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the medication Lisinopril 40 mg tablets. The contract has a firm fixed price of $1,053.60 and a completion date of May 6, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,968,306 tablets of Lisinopril 40 mg, a hypertension medication, at a ceiling value of $2,584.98. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of 1,000 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $1,344.35. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract has an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred ninety thousand six hundred sixty-four dollars to Amerisourcebergen Drug Corporation. The delivery order is for one thousand tablets of the pharmaceutical product Lisinopril 40 mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. The Defense Logistics Agency is a combat support agency under the United States Department of...
- The Defense Logistics Agency Troop Support Medical awarded a $48,460 delivery order to Amerisourcebergen Drug Corporation for 1,000 bottles of 40mg lisinopril tablets. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania by September 25, 2023, with performance beginning on September 22. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- The Defense Logistics Agency awarded a $72,660 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of the pharmaceutical lisinopril 40 mg. The prime contractor will deliver the products to its Conshohocken, Pennsylvania facility by July 7, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-five thousand three hundred twenty dollars and thirty-two cents ($145,320.32) to Amerisourcebergen Drug Corporation for one thousand (1,000) units of the pharmaceutical product Lisinopril 40mg tablets. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania under a start date of September 25, 2023 concluding on September 26, 2023. As a major provider of...
- The Defense Logistics Agency awarded a $157,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 20mg lisinopril. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 21, 2023 in support of the Defense Logistics Agency's pharmaceutical procurement programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceutical supply vehicle and will...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAMYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 1,000 tablets of Lisinopril 40 mg, with a ceiling value of $2,041.70 and an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside delivery order uses firm fixed price pricing and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal medical supply chain requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and systems including the Defense Health Agency and U.S. Coast Guard. The current award of Lisinopril represents one of numerous delivery orders issued against this master contract vehicle to fulfill ongoing federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/15/25 |